161 related articles for article (PubMed ID: 33806648)
1. Heterogeneous Nuclear Ribonucleoprotein K Is Involved in the Estrogen-Signaling Pathway in Breast Cancer.
Iwabuchi E; Miki Y; Suzuki T; Hirakawa H; Ishida T; Sasano H
Int J Mol Sci; 2021 Mar; 22(5):. PubMed ID: 33806648
[TBL] [Abstract][Full Text] [Related]
2. Estrogen receptor α dependent regulation of estrogen related receptor β and its role in cell cycle in breast cancer.
Madhu Krishna B; Chaudhary S; Mishra DR; Naik SK; Suklabaidya S; Adhya AK; Mishra SK
BMC Cancer; 2018 May; 18(1):607. PubMed ID: 29843638
[TBL] [Abstract][Full Text] [Related]
3. Co-expression of nuclear heterogeneous nuclear ribonucleic protein K and estrogen receptor α in endometrial cancer.
Miki Y; Iwabuchi E; Takagi K; Suzuki T; Sasano H; Yaegashi N; Ito K
Pathol Res Pract; 2022 Mar; 231():153795. PubMed ID: 35134625
[TBL] [Abstract][Full Text] [Related]
4. The GPER1/SPOP axis mediates ubiquitination-dependent degradation of ERα to inhibit the growth of breast cancer induced by oestrogen.
Zhang N; Sun P; Xu Y; Li H; Liu H; Wang L; Cao Y; Zhou K; TinghuaiWang
Cancer Lett; 2021 Feb; 498():54-69. PubMed ID: 33069770
[TBL] [Abstract][Full Text] [Related]
5. MAP kinase/estrogen receptor cross-talk enhances estrogen-mediated signaling and tumor growth but does not confer tamoxifen resistance.
Atanaskova N; Keshamouni VG; Krueger JS; Schwartz JA; Miller F; Reddy KB
Oncogene; 2002 Jun; 21(25):4000-8. PubMed ID: 12037682
[TBL] [Abstract][Full Text] [Related]
6. Estrogen induces estrogen-related receptor alpha gene expression and chromatin structural changes in estrogen receptor (ER)-positive and ER-negative breast cancer cells.
Hu P; Kinyamu HK; Wang L; Martin J; Archer TK; Teng C
J Biol Chem; 2008 Mar; 283(11):6752-63. PubMed ID: 18174157
[TBL] [Abstract][Full Text] [Related]
7. In situ detection of estrogen receptor dimers in breast carcinoma cells in archival materials using proximity ligation assay (PLA).
Iwabuchi E; Miki Y; Ono K; Onodera Y; Suzuki T; Hirakawa H; Ishida T; Ohuchi N; Sasano H
J Steroid Biochem Mol Biol; 2017 Jan; 165(Pt B):159-169. PubMed ID: 27264933
[TBL] [Abstract][Full Text] [Related]
8. Nuclear and extranuclear pathway inputs in the regulation of global gene expression by estrogen receptors.
Madak-Erdogan Z; Kieser KJ; Kim SH; Komm B; Katzenellenbogen JA; Katzenellenbogen BS
Mol Endocrinol; 2008 Sep; 22(9):2116-27. PubMed ID: 18617595
[TBL] [Abstract][Full Text] [Related]
9. Characterization of a membrane-associated estrogen receptor in breast cancer cells and its contribution to hormone therapy resistance using a novel selective ligand.
Niwa T; Takanobu J; Suzuki K; Sato Y; Yamaguchi Y; Hayashi SI
J Steroid Biochem Mol Biol; 2020 Jul; 201():105671. PubMed ID: 32289430
[TBL] [Abstract][Full Text] [Related]
10. KMT2C mediates the estrogen dependence of breast cancer through regulation of ERα enhancer function.
Gala K; Li Q; Sinha A; Razavi P; Dorso M; Sanchez-Vega F; Chung YR; Hendrickson R; Hsieh JJ; Berger M; Schultz N; Pastore A; Abdel-Wahab O; Chandarlapaty S
Oncogene; 2018 Aug; 37(34):4692-4710. PubMed ID: 29755131
[TBL] [Abstract][Full Text] [Related]
11. Heterogeneous nuclear ribonucleoprotein K promotes the progression of lung cancer by inhibiting the p53-dependent signaling pathway.
Li M; Yang X; Zhang G; Wang L; Zhu Z; Zhang W; Huang H; Gao R
Thorac Cancer; 2022 May; 13(9):1311-1321. PubMed ID: 35352475
[TBL] [Abstract][Full Text] [Related]
12. Estrogen-related Receptor β Reduces the Subnuclear Mobility of Estrogen Receptor α and Suppresses Estrogen-dependent Cellular Function.
Tanida T; Matsuda KI; Yamada S; Hashimoto T; Kawata M
J Biol Chem; 2015 May; 290(19):12332-45. PubMed ID: 25805499
[TBL] [Abstract][Full Text] [Related]
13. Activation of an estrogen/estrogen receptor signaling by BIG3 through its inhibitory effect on nuclear transport of PHB2/REA in breast cancer.
Kim JW; Akiyama M; Park JH; Lin ML; Shimo A; Ueki T; Daigo Y; Tsunoda T; Nishidate T; Nakamura Y; Katagiri T
Cancer Sci; 2009 Aug; 100(8):1468-78. PubMed ID: 19496786
[TBL] [Abstract][Full Text] [Related]
14. Stimulatory cross-talk between NFAT3 and estrogen receptor in breast cancer cells.
Zhang H; Xie X; Zhu X; Zhu J; Hao C; Lu Q; Ding L; Liu Y; Zhou L; Liu Y; Huang C; Wen C; Ye Q
J Biol Chem; 2005 Dec; 280(52):43188-97. PubMed ID: 16219765
[TBL] [Abstract][Full Text] [Related]
15. Estrogen and pure antiestrogen fulvestrant (ICI 182 780) augment cell-matrigel adhesion of MCF-7 breast cancer cells through a novel G protein coupled estrogen receptor (GPR30)-to-calpain signaling axis.
Chen Y; Li Z; He Y; Shang D; Pan J; Wang H; Chen H; Zhu Z; Wan L; Wang X
Toxicol Appl Pharmacol; 2014 Mar; 275(2):176-81. PubMed ID: 24440569
[TBL] [Abstract][Full Text] [Related]
16. Gli activation by the estrogen receptor in breast cancer cells: Regulation of cancer cell growth by Gli3.
Massah S; Foo J; Li N; Truong S; Nouri M; Xie L; Prins GS; Buttyan R
Mol Cell Endocrinol; 2021 Feb; 522():111136. PubMed ID: 33347954
[TBL] [Abstract][Full Text] [Related]
17. PROX1 promotes breast cancer invasion and metastasis through WNT/β-catenin pathway via interacting with hnRNPK.
Zhu L; Tian Q; Gao H; Wu K; Wang B; Ge G; Jiang S; Wang K; Zhou C; He J; Liu P; Ren Y; Wang B
Int J Biol Sci; 2022; 18(5):2032-2046. PubMed ID: 35342346
[No Abstract] [Full Text] [Related]
18. Metalloestrogenic effects of cadmium are absent in long-term estrogen-deprived MCF-7 cells: Evidence for the involvement of constitutively activated estrogen receptor α and very low expression of G protein-coupled estrogen receptor 1.
Hirao-Suzuki M; Takeda S; Kodama Y; Takiguchi M; Toda A; Ohara M
Toxicol Lett; 2020 Feb; 319():22-30. PubMed ID: 31689473
[TBL] [Abstract][Full Text] [Related]
19. YAP mediates the positive regulation of hnRNPK on the lung adenocarcinoma H1299 cell growth.
Xu L; Zhang T; Huang W; Liu X; Lu J; Gao X; Zhang YF; Liu L
Acta Biochim Biophys Sin (Shanghai); 2019 Jul; 51(7):677-687. PubMed ID: 31187136
[TBL] [Abstract][Full Text] [Related]
20. Endocrine therapy resistance can be associated with high estrogen receptor alpha (ERalpha) expression and reduced ERalpha phosphorylation in breast cancer models.
Kuske B; Naughton C; Moore K; Macleod KG; Miller WR; Clarke R; Langdon SP; Cameron DA
Endocr Relat Cancer; 2006 Dec; 13(4):1121-33. PubMed ID: 17158758
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]